Retrophin (RTRX) PT Trimmed to $44 at Leerink Partners Post Q3, 'Outperform' Maintained
Leerink Partners analyst Joseph Schwartz reiterated an Outperform rating but lowered his price target on Retrophin (NASDAQ: RTRX) to $44.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)